There are two main barriers stifling the development of telehomecare in the UK. First, the complexity of providing an end-to-end service from referral to response and second the lack of a large scale market to drive investment. This chapter identifies the “prescribed” market and the “elective” market, the former being within the public sector and the latter a new and potentially very large service for those not covered by public sector provision. The elective market includes preventative care thus addressing important public health agendas. To realise its potential, telehomecare needs to become part of the fabric of life. It will not do so until there is a robust delivery infrastructure, interoperable products and a clear regulatory framework. This chapter discusses some of these issues.